Amgen Inc (AMGN)
311.29
+32.90
(+11.82%)
USD |
NASDAQ |
May 03, 16:00
311.41
+0.12
(+0.04%)
After-Hours: 20:00
Amgen Free Cash Flow: 7.098B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.098B |
| December 31, 2023 | 7.359B |
| September 30, 2023 | 9.379B |
| June 30, 2023 | 9.685B |
| March 31, 2023 | 7.531B |
| December 31, 2022 | 8.785B |
| September 30, 2022 | 8.997B |
| June 30, 2022 | 8.355B |
| March 31, 2022 | 8.417B |
| December 31, 2021 | 8.381B |
| September 30, 2021 | 7.84B |
| June 30, 2021 | 8.897B |
| March 31, 2021 | 9.835B |
| December 31, 2020 | 9.889B |
| September 30, 2020 | 10.24B |
| June 30, 2020 | 10.21B |
| March 31, 2020 | 8.795B |
| December 31, 2019 | 8.532B |
| September 30, 2019 | 9.175B |
| June 30, 2019 | 9.07B |
| March 31, 2019 | 9.715B |
| December 31, 2018 | 10.56B |
| September 30, 2018 | 10.45B |
| June 30, 2018 | 10.64B |
| March 31, 2018 | 10.87B |
| Date | Value |
|---|---|
| December 31, 2017 | 10.51B |
| September 30, 2017 | 10.53B |
| June 30, 2017 | 9.825B |
| March 31, 2017 | 10.07B |
| December 31, 2016 | 9.616B |
| September 30, 2016 | 8.611B |
| June 30, 2016 | 8.821B |
| March 31, 2016 | 9.532B |
| December 31, 2015 | 9.137B |
| September 30, 2015 | 9.773B |
| June 30, 2015 | 9.39B |
| March 31, 2015 | 8.343B |
| December 31, 2014 | 7.949B |
| September 30, 2014 | 7.079B |
| June 30, 2014 | 6.29B |
| March 31, 2014 | 5.677B |
| December 31, 2013 | 5.598B |
| September 30, 2013 | 4.551B |
| June 30, 2013 | 4.469B |
| March 31, 2013 | 5.231B |
| December 31, 2012 | 5.168B |
| September 30, 2012 | 5.941B |
| June 30, 2012 | 5.24B |
| March 31, 2012 | 4.45B |
| December 31, 2011 | 4.552B |
Free Cash Flow Range, Past 5 Years
7.098B
Minimum
Mar 2024
10.24B
Maximum
Sep 2020
8.823B
Average
8.846B
Median
Free Cash Flow Benchmarks
| Gilead Sciences Inc | 8.481B |
| Johnson & Johnson | 18.23B |
| Eli Lilly and Co | -3.896B |
| Merck & Co Inc | 9.143B |
| Vertex Pharmaceuticals Inc | 3.279B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 689.00M |
| Cash from Investing (Quarterly) | -217.00M |
| Cash from Financing (Quarterly) | -1.708B |
| Free Cash Flow Per Share (Quarterly) | 0.8563 |
| Free Cash Flow to Equity (Quarterly) | 1.052B |
| Free Cash Flow to Firm (Quarterly) | 1.828B |
| Free Cash Flow Yield | 4.24% |